ERBB2 and neoplasm: Thus, the present study examined the effect of pAkt and pErk1/2 expression on the following tumor subgroups: HER2-positive; HER2-negative; ER- or PR-positive; ER- and PR-negative; lymph node-positive; and lymph node-negative subgroups.